Boditech Med Inc.

Equities

A206640

KR7206640005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
17,370 ^KRW	+0.35%		+8.29%	-15.27%

Feb. 21	4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	CI
2023	Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	CI

Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.

June 13, 2022 at 01:31 am EDT

From January 1, 2022 to June 13, 2022, the company has repurchased 70,596 shares, representing 0.31% for KRW 1,134.52 million. With this, the company has completed the repurchase of 297,901 shares, representing 1.31% for KRW 4,987.06 million under the buyback announced on December 14, 2021.

Latest news about Boditech Med Inc.

4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	Feb. 20	CI
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	23-08-31	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	23-03-27	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	23-03-27	CI
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million	23-03-27	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	22-12-28	CI
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement	22-11-15	CI
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	22-09-29	CI
Boditech Med Inc. authorizes a Buyback Plan.	22-09-28	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	22-06-13	CI
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.	22-06-12	CI
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies	22-03-29	MT
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America	22-03-29	CI
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D	22-03-24	CI
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America	22-03-22	CI
Boditech Med to Expand to U.S., North America	22-03-18	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	22-03-14	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	22-03-04	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	22-03-04	CI
Boditech Med Inc.'s Equity Buyback announced on September 6, 2021, has expired with 154,561 shares, representing 0.67% for KRW 2,990.39 million.	22-03-03	CI
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	21-12-13	CI
Boditech Med Inc. authorizes a Buyback Plan.	21-12-13	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on April 13, 2021.	21-10-18	CI
Boditech Med Inc.'s Equity Buyback announced on April 13, 2021, has expired with 137,643 shares, representing 0.6% for KRW 2,997.58 million.	21-10-11	CI
Boditech Med Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares.	21-09-06	CI

Chart Boditech Med Inc.

Duration

Period

More charts

Company Profile

Boditech Med Inc is a Korea-based company principally engaged in the manufacture and sale of medical equipment. The Company is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The Company sells its products within domestic market and to overseas markets. The Company was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Boditech Med Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17,370 KRW

Average target price

26,000 KRW

Spread / Average Target

+49.68%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BODITECH MED INC.	-15.27%	282M
SARTORIUS AG	-18.70%	18.12B
QUIDELORTHO CORPORATION	-41.90%	2.87B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+19.36%	1.9B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-1.05%	1.65B
BIOTAGE AB	+34.18%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.83%	957M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.96%	896M
REVENIO GROUP OYJ	+11.19%	841M
VAREX IMAGING CORPORATION	-26.98%	612M

Medical Diagnostic & Testing Equipment